Potential Benefits of N-Acetylcysteine in Preventing Pregabalin-Induced Seeking-Like Behavior Article (Faculty180)

cited authors

  • Almalki, Atia H; Alsaab, Hashem O; Alsanie, Walaa F; Gaber, Ahmed; Alkhalifa, Turki; Almalki, Ahmad; Alzahrani, Omar; Hardy, Ana Maria Gregio; Alhadidi, Qasim; Shah, Z A; Althobaiti, Yu S


  • Substance-use disorder is globally prevalent and responsible for numerous social and medical problems. Pregabalin (Lyrica), typically used to treat diabetic neuropathy, has recently emerged as a drug of abuse. Drug abuse is associated with several neuronal changes, including the downregulation of glutamate transporters such as glutamate transporter 1 and cystine/glutamate antiporter. We investigated the effects of N-acetylcysteine, a glutamate transporter 1 and xCT upregulator, on pregabalin addiction using a conditioned place preference paradigm. Pregabalin (60 mg/kg) was found to induce conditioned place preference when compared to a vehicle. A 100 mg/kg dose of N-acetylcysteine was found to block pregabalin-seeking behaviors. These results support previous findings showing that glutamate transporters play an important role in pregabalin-induced seeking behaviors. N-acetylcysteine may represent a beneficial agent in preventing the abuse potential of pregabalin.


publication date

  • 2021

published in


  • 9